Blog July 9, 2021
Last month, in what was instantly hailed as one of the most controversial drug approvals in decades, the FDA granted accelerated approval to Biogen’s Aduhelm, the first new Alzheimer’s treatment to receive approval in nearly 20 years.
Blog June 30, 2021
When your customers are physicians, bombarded round the clock with all manner of data and promotion, one fundamental line of thinking can be groundbreaking. What is the motivational style of your target provider type?
Blog June 24, 2021
The much-anticipated 2021 ASCO Annual Meeting has come and gone, and we have experienced a lot: over 5000 abstracts, almost 300 booths and exhibits, and 17 industry expert theaters.
Blog June 17, 2021
It’s been shown over and over that women utilize healthcare services way more than men, being 33% more likely overall to visit a doctor. According to a recent Cleveland Clinic survey, more than 40% of men see a doctor only when they fear they have a serious illness.
Blog June 10, 2021
In a highly anticipated decision, the Food and Drug Administration (FDA) last week cleared Alzheimer’s disease drug aducanumab on an accelerated, conditional approval program.
Blog June 3, 2021
Any diagnosis that contains the word “cancer” can be a heartstopper. Even less aggressive cancers carry a unique weight. However the word attained that gravity, it makes it one of the scariest diagnoses a human being can get.
Blog June 2, 2021
Regardless of whether we’d like to admit it, many of us gained unwanted pounds during the pandemic. Nicknamed the “Quarantine 19,” memes and viral videos took over the Internet, making light of weight gain during the past year.
Blog May 27, 2021
As we’ve inched past the year mark of the pandemic, amidst the heartache of what has transpired and the fear of what is yet to come, there is an ironic undercurrent of collective chest-puffing—and rightly so.
Blog May 26, 2021
As Amazon and Walmart’s endeavors in the healthcare space continue to advance, the choices the two giants make are aligned to their respective company cultures.
Blog May 20, 2021
Take a cursory look at the agenda for next month’s ASCO, and you’ll see oncology’s newest innovations—and promise—come with ever-increasing complexity of choices.
Blog May 18, 2021
As you may have read, the Biden administration announced last week that it will support a proposal to temporarily waive certain intellectual property (IP) protections for COVID-19 vaccines and therapies.
Blog May 14, 2021
All too often, even the most carefully designed—and historically successful—brand strategies may falter as they meet with new audiences. These new audiences can be critical targets, but they’re beyond the sphere for which the brand was initially positioned.
Blog May 7, 2021
While many people, especially healthcare insiders, understand the manifold benefits of artificial intelligence (AI), it’s gotten a bad rep over the years.
Blog April 30, 2021
At Adexchanger’s recent Identity Day, part of a virtual series about trends in data-driven marketing, one hot topic was the announcement of the end of third-party cookies from Google.
Blog April 19, 2021
This VR-based tool is changing the way major companies like eBay, Amazon and Google are approaching diversity training. It could also spotlight a new opportunity for healthcare organizations looking to become a true catalyst for change.
Blog April 16, 2021
Democrats have revealed that the next major legislative package—colloquially known as the infrastructure package—will likely include provisions to lower prescription drug prices. It will be used in part to pay for the infrastructure bill.
Blog April 9, 2021
With about 700 million COVID-19 vaccine doses administered across the globe, the return to (relative) normalcy, in many parts of the world, is starting to feel closer and closer.
Blog April 2, 2021
Maybe you’ve spent some of your career working on initiatives that empower patients to make sound health decisions, such as by developing quality content that’s easy for them to find.
Blog March 25, 2021
The pandemic has forced many brands and businesses to re-strategize, postpone important initiatives or pivot offerings.
Blog March 17, 2021
The J&J COVID-19 vaccine has been approved by the FDA after showing a significant protective effect against severe disease after one dose.
Blog March 15, 2021
While we have come to see tech as a major opportunity to reduce the frictions we experience in our everyday lives, the increasing adoption of it is likely to create new challenges and amplify existing ones in our world following the pandemic.
Blog March 9, 2021
As a social media millennial at Syneos Health™, connecting the world of TikTok—one of the hottest social media channels today—and healthcare was a challenge I couldn’t pass up.
Blog March 5, 2021
The new, third wave of the Syneos Health™ study “Telemedicine Use and Field Force Engagement in the COVID-19 Era and Beyond,” available to download now, reveals important physician attitudes and dynamics with respect to telemedicine use at this stage of the pandemic.
Blog March 1, 2021
Given the totally upending effects of the COVID-19 crisis, it may be easy to forget that it started during another public health crisis, the opioid epidemic—but now we’re starting to see the devastating impact of the confluence of the two.
Blog February 15, 2021
Americans may be the least aware of any population worldwide of the health effects of global warming, according to a study in Current Environmental Health Reports.
Blog February 4, 2021
This month, Syneos Health led a precision-targeting webinar with MM&M, delving into how COVID-19 continues to challenge conventional healthcare marketing and how brands can quickly adapt.
Blog November 19, 2020
The promotion of CBD products raises complex issues. Many of the options available for marijuana advertisers are currently restricted. And mainstream advertising is a complex prospect, even in states where many forms of cannabis are legal.
Blog November 10, 2020
The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.
Blog October 15, 2020
A new unbranded disease campaign Find the Right Fit launched by Jazz Pharmaceuticals seeks to support rare disease patients with myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (sAML) as they move throughout their diagnosis and treatment journey.
Blog October 8, 2020
Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19. They’ve taken advantage of the reset opportunity to cater to patients more effectively and productively.
Already have a RSS feed reader?
